Prevalence of Hypovitaminosis D and Factors Associated With Vitamin D Deficiency and Morbidity Among HIV-Infected Patients Enrolled in a Large Italian Cohort
Authors:
- Alessandro Cozzi-LepriACAlessandro Cozzi-Lepri
- Marco BorderiMBMarco Borderi
- Maria Carla ReMRMaria Carla Re
- Franco MaggioloFMFranco Maggiolo
- Andrea De LucaALAndrea De Luca
- Giovanni CassolaGCGiovanni Cassola
- Vincenzo VulloVVVincenzo Vullo
- Giampiero CarosiGCGiampiero Carosi
- Andrea AntinoriAAAndrea Antinori
- Valerio TozziVTValerio Tozzi
- Antonella Darminio MonforteAntonella Darminio Monforte
- 1 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 58 (2) , 163-172
Abstract
Background: A high prevalence of hypovitaminosis D (hypD) in HIV-infected patients has been reported, but reasons are unclear. Methods: The 25 hydroxy vitamin D (vitD) concentration was measured in a sample of HIV-positive patients from Italy enrolled in the Icona Foundation Study. The change in absolute levels of vitD pre/post combination antiretroviral treatment was modelled by linear regression controlling for confounders and seasonality. Factors associated with hypD were identified using logistic regression analysis, and survival analysis was employed to evaluate the prognostic value of vitD concentration to predict severe diseases (diabetes, cardiovascular, renal), AIDS, and death. Results: We studied 810 patients contributing 1408 vitD measures. Median age was 36 years (range: 20-69). VitD insufficiency (30-75 nmol/L) and deficiency (P = 0.04], the sample being collected in spring (OR: 11.27, P = 0.001) or in winter (OR: 4.22, P = 0.03) vs. summer, and a previous history of severe diseases (OR: 5.43, P = 0.03) or AIDS (OR: 2.44, P = 0.04). Over a median follow-up of 6.3 years, patients with vitD insufficiency were at higher risk of subsequent severe diseases than those with normal levels (relative hazard = 1.60, P = 0.05). Conclusions: Our analysis shows that despite the relatively young age of our HIV-infected population, the prevalence of hypD was high. Classic risk factors for hypD in the general population were confirmed in this setting. HypD seems to be moderately associated with the risk of severe disease, AIDS, and death.Keywords
This publication has 32 references indexed in Scilit:
- Systematic Review: Vitamin D and Cardiometabolic OutcomesAnnals of Internal Medicine, 2010
- Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysisMaturitas, 2010
- Vitamin D Status, Parathyroid Function, Bone Turnover, and BMD in Postmenopausal Women With Osteoporosis: Global PerspectiveJournal of Bone and Mineral Research, 2009
- Vitamin D DeficiencyJACC, 2008
- Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary AngiographyThe Journal of Clinical Endocrinology & Metabolism, 2008
- Independent Association of Low Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels With All-Cause and Cardiovascular MortalityArchives of internal medicine (1960), 2008
- Vitamin D status and response to treatment in post-menopausal osteoporosisOsteoporosis International, 2008
- The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2007
- Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomesThe American Journal of Clinical Nutrition, 2006
- Estimates of optimal vitamin D statusOsteoporosis International, 2005